American Heart Association
Hypertrophy and Heart Failure
Moderated Digital Poster Session
Zone 2, Moderated Digital Poster 10
Nov 18th , 11:10 AM - 12:35 PM
Li Yuting, Zhou Xiaoxia
Final Pr. ID: MDP1364
Authors: Li Yuting, Zhou Xiaoxia
Keywords: Cardiac hypertrophy , Heart failure
Miller Luke, Maddahi Yaniv, Roma Nicholas, Pattoli Megan, Shirani Jamshid
Final Pr. ID: MDP1365
Authors: Miller Luke, Maddahi Yaniv, Roma Nicholas, Pattoli Megan, Shirani Jamshid
Keywords: Hypertrophic cardiomyopathy , Ischemia , Coronary vessels
11 : 30 AM
The Cardiomyocyte Hypertrophy Inhibitor RFN-409, Identified by High Throughput Screening Assay, Suppresses Pressure Overload-induced Systolic Dysfunction in Mice by Suppressing p38 Activity
Irokawa Yudai, Katanasaka Yasufumi, Hasegawa Koji, Morimoto Tatsuya, Katagiri Takahiro, Maeda Risa, Shimizu Satoshi, Funamoto Masafumi, Hamabe Toshihide, Sunagawa Yoichi, Kawase Yuto, Naruta Ryuya
Final Pr. ID: MDP1366
Authors: Irokawa Yudai, Katanasaka Yasufumi, Hasegawa Koji, Morimoto Tatsuya, Katagiri Takahiro, Maeda Risa, Shimizu Satoshi, Funamoto Masafumi, Hamabe Toshihide, Sunagawa Yoichi, Kawase Yuto, Naruta Ryuya
Keywords: Cardiac hypertrophy , Pharmacology
11 : 40 AM
Comparison of Alcohol Septal Ablation with Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Samhan Ashraf, Choudhury Lubna, Saleh Danish, Kim Ellis, Hu Mo, Mueller Kayla, Garza Abigail, Baldridge Abigail, Puthumana Jyothy, Flaherty James
Final Pr. ID: MDP1367
Authors: Samhan Ashraf, Choudhury Lubna, Saleh Danish, Kim Ellis, Hu Mo, Mueller Kayla, Garza Abigail, Baldridge Abigail, Puthumana Jyothy, Flaherty James
Keywords: Hypertrophic cardiomyopathy , Myosin , Intervention
11 : 50 AM
Long-term effectiveness and safety of mavacamten in a real-world, multi-center, global study: Preliminary results of COLLIGO-HCM from a diverse cohort in the United States
Macnamara James, Orlandi Paula, Li Leanne, Pichardo Angel, Bilen Ozlem, Adler Arnon, Maor Elad, Bastiaenen Rachel, Gold Matthew, Maksabedian Hernandez Ervant, Han Xu, Schuler Patricia, Salazar-mendiguchia Joel
Final Pr. ID: MDP1368
Authors: Macnamara James, Orlandi Paula, Li Leanne, Pichardo Angel, Bilen Ozlem, Adler Arnon, Maor Elad, Bastiaenen Rachel, Gold Matthew, Maksabedian Hernandez Ervant, Han Xu, Schuler Patricia, Salazar-mendiguchia Joel
Keywords: Hypertrophic cardiomyopathy
12 : 00 PM
Early Insights on Mavacamten Usage in Canada: A Retrospective Cohort Study of the Patient Support Program
Ong Kevin Chun, Crean Andrew, Garceau Patrick, Moeller Andrew, Brellier Florence, Corriveau Stephanie, Ward Michael
Final Pr. ID: MDP1369
Authors: Ong Kevin Chun, Crean Andrew, Garceau Patrick, Moeller Andrew, Brellier Florence, Corriveau Stephanie, Ward Michael
Keywords: Cardiology , Cardiac hypertrophy , Cardiomyopathy , Cardiovascular disease , Hypertrophic cardiomyopathy
12 : 10 PM
Real-world Long-term Effectiveness of Mavacamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: a Multicenter Observational Study (MARVEL-HCM)
Abraham Theodore, Kim Mi-ok, Schuler Patricia, Dubey Anand, Alsidawi Said, Martinez Matthew, Wheeler Matthew, Roehl Kaitlin, Patel Ruchi, Soutar Marybeth, Herry Morgane, Wang Annie
Final Pr. ID: MDP1370
Authors: Abraham Theodore, Kim Mi-ok, Schuler Patricia, Dubey Anand, Alsidawi Said, Martinez Matthew, Wheeler Matthew, Roehl Kaitlin, Patel Ruchi, Soutar Marybeth, Herry Morgane, Wang Annie
Keywords: Hypertrophic cardiomyopathy
12 : 20 PM
Integrated safety and tolerability of mavacamten treatment over 5 years in patients with obstructive hypertrophic cardiomyopathy
Owens Anjali, Chen Yu Mao, Wang Andrew, Barriales-villa Roberto, Desai Milind, Garcia-pavia Pablo, Hagege Albert, Olivotto Iacopo, Wojakowski Wojtek, Afsari Sonia, Balaratnam Ganesh
Final Pr. ID: MDP1371
Authors: Owens Anjali, Chen Yu Mao, Wang Andrew, Barriales-villa Roberto, Desai Milind, Garcia-pavia Pablo, Hagege Albert, Olivotto Iacopo, Wojakowski Wojtek, Afsari Sonia, Balaratnam Ganesh
Keywords: Hypertrophic cardiomyopathy
11 : 40 AM
Comparison of Alcohol Septal Ablation with Mavacamten in Obstructive Hypertrophic Cardiomyopathy
Samhan Ashraf, Choudhury Lubna, Saleh Danish, Kim Ellis, Hu Mo, Mueller Kayla, Garza Abigail, Baldridge Abigail, Puthumana Jyothy, Flaherty James
Final Pr. ID: MDP1367
Authors: Samhan Ashraf, Choudhury Lubna, Saleh Danish, Kim Ellis, Hu Mo, Mueller Kayla, Garza Abigail, Baldridge Abigail, Puthumana Jyothy, Flaherty James
Keywords: Hypertrophic cardiomyopathy , Myosin , Intervention
Miller Luke, Maddahi Yaniv, Roma Nicholas, Pattoli Megan, Shirani Jamshid
Final Pr. ID: MDP1365
Authors: Miller Luke, Maddahi Yaniv, Roma Nicholas, Pattoli Megan, Shirani Jamshid
Keywords: Hypertrophic cardiomyopathy , Ischemia , Coronary vessels
12 : 00 PM
Early Insights on Mavacamten Usage in Canada: A Retrospective Cohort Study of the Patient Support Program
Ong Kevin Chun, Crean Andrew, Garceau Patrick, Moeller Andrew, Brellier Florence, Corriveau Stephanie, Ward Michael
Final Pr. ID: MDP1369
Authors: Ong Kevin Chun, Crean Andrew, Garceau Patrick, Moeller Andrew, Brellier Florence, Corriveau Stephanie, Ward Michael
Keywords: Cardiology , Cardiac hypertrophy , Cardiomyopathy , Cardiovascular disease , Hypertrophic cardiomyopathy
12 : 20 PM
Integrated safety and tolerability of mavacamten treatment over 5 years in patients with obstructive hypertrophic cardiomyopathy
Owens Anjali, Chen Yu Mao, Wang Andrew, Barriales-villa Roberto, Desai Milind, Garcia-pavia Pablo, Hagege Albert, Olivotto Iacopo, Wojakowski Wojtek, Afsari Sonia, Balaratnam Ganesh
Final Pr. ID: MDP1371
Authors: Owens Anjali, Chen Yu Mao, Wang Andrew, Barriales-villa Roberto, Desai Milind, Garcia-pavia Pablo, Hagege Albert, Olivotto Iacopo, Wojakowski Wojtek, Afsari Sonia, Balaratnam Ganesh
Keywords: Hypertrophic cardiomyopathy
11 : 50 AM
Long-term effectiveness and safety of mavacamten in a real-world, multi-center, global study: Preliminary results of COLLIGO-HCM from a diverse cohort in the United States
Macnamara James, Orlandi Paula, Li Leanne, Pichardo Angel, Bilen Ozlem, Adler Arnon, Maor Elad, Bastiaenen Rachel, Gold Matthew, Maksabedian Hernandez Ervant, Han Xu, Schuler Patricia, Salazar-mendiguchia Joel
Final Pr. ID: MDP1368
Authors: Macnamara James, Orlandi Paula, Li Leanne, Pichardo Angel, Bilen Ozlem, Adler Arnon, Maor Elad, Bastiaenen Rachel, Gold Matthew, Maksabedian Hernandez Ervant, Han Xu, Schuler Patricia, Salazar-mendiguchia Joel
Keywords: Hypertrophic cardiomyopathy
12 : 10 PM
Real-world Long-term Effectiveness of Mavacamten in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: a Multicenter Observational Study (MARVEL-HCM)
Abraham Theodore, Kim Mi-ok, Schuler Patricia, Dubey Anand, Alsidawi Said, Martinez Matthew, Wheeler Matthew, Roehl Kaitlin, Patel Ruchi, Soutar Marybeth, Herry Morgane, Wang Annie
Final Pr. ID: MDP1370
Authors: Abraham Theodore, Kim Mi-ok, Schuler Patricia, Dubey Anand, Alsidawi Said, Martinez Matthew, Wheeler Matthew, Roehl Kaitlin, Patel Ruchi, Soutar Marybeth, Herry Morgane, Wang Annie
Keywords: Hypertrophic cardiomyopathy
Li Yuting, Zhou Xiaoxia
Final Pr. ID: MDP1364
Authors: Li Yuting, Zhou Xiaoxia
Keywords: Cardiac hypertrophy , Heart failure
11 : 30 AM
The Cardiomyocyte Hypertrophy Inhibitor RFN-409, Identified by High Throughput Screening Assay, Suppresses Pressure Overload-induced Systolic Dysfunction in Mice by Suppressing p38 Activity
Irokawa Yudai, Katanasaka Yasufumi, Hasegawa Koji, Morimoto Tatsuya, Katagiri Takahiro, Maeda Risa, Shimizu Satoshi, Funamoto Masafumi, Hamabe Toshihide, Sunagawa Yoichi, Kawase Yuto, Naruta Ryuya
Final Pr. ID: MDP1366
Authors: Irokawa Yudai, Katanasaka Yasufumi, Hasegawa Koji, Morimoto Tatsuya, Katagiri Takahiro, Maeda Risa, Shimizu Satoshi, Funamoto Masafumi, Hamabe Toshihide, Sunagawa Yoichi, Kawase Yuto, Naruta Ryuya
Keywords: Cardiac hypertrophy , Pharmacology